HENRY L SCHAIRER
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ALLENTOWN, PA NPI 1578554192
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology PA Aurinia Pharma U.S., Inc. All categories
General Payments — all program years on this page
$716.95
- Category: General Payments
- Program years: PY2018–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $469.58 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.58 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Aurinia Pharma U.S., Inc. | $124.80 | 1 |
| Retrophin, Inc. | $124.74 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $106.80 | 1 |
| Amgen Inc. | $59.55 | 2 |
| Ardelyx, Inc. | $31.42 | 2 |
| Relypsa, Inc. | $22.27 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1111699346 | Amgen Inc. | $26.59 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111699348 | Amgen Inc. | $32.96 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118065628 | Boehringer Ingelheim Pharmaceuticals, Inc. | $106.80 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124038195 | Vifor Pharma, Inc. | $22.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146706147 | Ardelyx, Inc. | $14.55 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146706149 | Ardelyx, Inc. | $16.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149894410 | Travere Therapeutics, Inc. | $124.74 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150691598 | Aurinia Pharma U.S., Inc. | $124.80 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.